{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:50:38Z","timestamp":1789537838477,"version":"build-2803163510"},"reference-count":26,"publisher":"The Endocrine Society","issue":"9","funder":[{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation for Advanced Research In Hypertension and Cardiovascular Diseases (FORICA)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Accumulating evidence suggests a link between adrenocortical zona glomerulosa and parathyroid gland through mechanisms that remain unexplored.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To test the hypothesis that in vivo angiotensin II blockade affects PTH secretion in patients with hypertension and that aldosterone and angiotensim II directly stimulate PTH secretion ex vivo.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design and Setting<\/jats:title>\n                  <jats:p>We investigated the changes of serum PTH levels induced by oral captopril (50 mg) administration in patients with primary essential hypertension (EH) and with primary aldosteronism (PA) caused by bilateral adrenal hyperplasia (BAH) or aldosterone-producing adenoma (APA), the latter before and after adrenalectomy. We also exposed primary cultures of human parathyroid cells from patients with primary hyperparathyroidism to angiotensin II (10\u22127 M) and\/or aldosterone (10\u22127 M).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Captopril lowered PTH levels (in nanograms per liter) both in patients with EH (n = 63; 25.9 \u00b1 8.3 baseline vs 24.4 \u00b1 8.0 postcaptopril, P &lt; 0.0001) and in patients with APA after adrenalectomy (n = 27; 26.3 \u00b1 11.6 vs 24.0 \u00b1 9.7 P = 0.021). However, it was ineffective in patients with full-blown PA caused by APA and BAH. In primary culture of human parathyroid cells, both aldosterone (P &lt; 0.001) and angiotensin II (P = 0.002) markedly increased PTH secretion from baseline, by acting through mineralocorticoid receptor and angiotensin type 1 receptor, as these effects were abolished by canrenone and irbesartan, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>These results collectively suggest an implication of the renin-angiotensin-aldosterone system in PTH regulation in humans, at least in PTH-secreting cells obtained from parathyroid tumors. Moreover, they further support the concept that mild hyperparathyroidism is a feature of human PA that is correctable with adrenalectomy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2019-00143","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T09:06:53Z","timestamp":1552468013000},"page":"3726-3734","source":"Crossref","is-referenced-by-count":30,"title":["PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy"],"prefix":"10.1210","volume":"104","author":[{"given":"Livia","family":"Lenzini","sequence":"first","affiliation":[{"name":"Hypertension Unit, Department of Medicine-DIMED, University of Medicine of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selene","family":"Prisco","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Department of Medicine-DIMED, University of Medicine of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Emmanuel","family":"Vanderriele","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Department of Medicine-DIMED, University of Medicine of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Lerco","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Department of Medicine-DIMED, University of Medicine of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Torresan","sequence":"additional","affiliation":[{"name":"Endocrine Surgery Unit, Department of Surgery, Oncology and Gastroenterolgy, University of Padua, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Maiolino","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Department of Medicine-DIMED, University of Medicine of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Maria","family":"Seccia","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Department of Medicine-DIMED, University of Medicine of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Iacobone","sequence":"additional","affiliation":[{"name":"Endocrine Surgery Unit, Department of Surgery, Oncology and Gastroenterolgy, University of Padua, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7963-0931","authenticated-orcid":false,"given":"Gian Paolo","family":"Rossi","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Department of Medicine-DIMED, University of Medicine of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2019,3,13]]},"reference":[{"issue":"11","key":"2019072014595019800_bib1","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2019072014595019800_bib2","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/0895-7061(95)00182-O","article-title":"Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas","volume":"8","author":"Rossi","year":"1995","journal-title":"Am J Hypertens"},{"issue":"3","key":"2019072014595019800_bib3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0002-9343(85)90328-6","article-title":"Calcium metabolism and parathyroid function in primary aldosteronism","volume":"78","author":"Resnick","year":"1985","journal-title":"Am J Med"},{"issue":"2","key":"2019072014595019800_bib4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/HJH.0b013e32834f0451","article-title":"Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism","volume":"30","author":"Maniero","year":"2012","journal-title":"J Hypertens"},{"issue":"1","key":"2019072014595019800_bib5","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1210\/jc.2011-2183","article-title":"Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study","volume":"97","author":"Pilz","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019072014595019800_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/HYPERTENSIONAHA.112.195891","article-title":"Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma","volume":"60","author":"Rossi","year":"2012","journal-title":"Hypertension"},{"issue":"2","key":"2019072014595019800_bib7","doi-asserted-by":"crossref","first-page":"E209","DOI":"10.1152\/ajpendo.2001.280.2.E209","article-title":"PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells","volume":"280","author":"Mazzocchi","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"2019072014595019800_bib8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/endo-129-1-489","article-title":"Parathyroid hormone modulates angiotensin II-induced aldosterone secretion from the adrenal glomerulosa cell","volume":"129","author":"Isales","year":"1991","journal-title":"Endocrinology"},{"issue":"5","key":"2019072014595019800_bib9","first-page":"309","article-title":"Enhancement of the stimulatory effect of calcium on aldosterone secretion by parathyroid hormone","volume":"20","author":"Olgaard","year":"1994","journal-title":"Miner Electrolyte Metab"},{"issue":"3","key":"2019072014595019800_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1677\/joe.0.1120431","article-title":"Response of adrenal cells to parathyroid hormone stimulation","volume":"112","author":"Rosenberg","year":"1987","journal-title":"J Endocrinol"},{"issue":"5","key":"2019072014595019800_bib11","doi-asserted-by":"crossref","first-page":"H2023","DOI":"10.1152\/ajpheart.00477.2004","article-title":"Loss of bone minerals and strength in rats with aldosteronism","volume":"287","author":"Chhokar","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"2019072014595019800_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.metabol.2013.08.016","article-title":"Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease","volume":"63","author":"Tomaschitz","year":"2014","journal-title":"Metabolism"},{"issue":"3","key":"2019072014595019800_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/HYPERTENSIONAHA.111.173948","article-title":"Primary hyperparathyroidism with concurrent primary aldosteronism","volume":"58","author":"Maniero","year":"2011","journal-title":"Hypertension"},{"issue":"3","key":"2019072014595019800_bib14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/hr.2010.251","article-title":"Hyperparathyroidism, arterial hypertension and aortic stiffness: a possible bidirectional link between the adrenal cortex and the parathyroid glands that causes vascular damage","volume":"34","author":"Rossi","year":"2011","journal-title":"Hypertens Res"},{"issue":"2","key":"2019072014595019800_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/HYPERTENSIONAHA.113.01910","article-title":"Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone","volume":"63","author":"Brown","year":"2014","journal-title":"Hypertension"},{"key":"2019072014595019800_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/4138783","article-title":"Angiotensin-converting enzyme inhibition and parathyroid hormone secretion","volume":"2017","author":"Zaheer","year":"2017","journal-title":"Int J Endocrinol"},{"issue":"9","key":"2019072014595019800_bib17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2019072014595019800_bib18","first-page":"1029","article-title":"The biology of normal zona glomerulosa and aldosterone-producing adenoma: pathological implications","volume":"39","author":"Seccia","year":"2018","journal-title":"Endocr Rev"},{"issue":"9","key":"2019072014595019800_bib19","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1515\/cclm-2015-1094","article-title":"Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension","volume":"54","author":"Rossi","year":"2016","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"2019072014595019800_bib20","doi-asserted-by":"crossref","first-page":"CS20171593","DOI":"10.1042\/CS20171593","article-title":"The angiotensin type 2 receptor in human adrenocortical zona glomerulosa and in aldosterone-producing adenoma: low Expression and no functional role","volume":"132","author":"Vanderriele","year":"2018","journal-title":"Clin Sci (Lond)"},{"key":"2019072014595019800_bib21","doi-asserted-by":"crossref","unstructured":"Lenzini\n              L\n            , PriscoS, VanderrielePE, LercoS, TorresanF, MaiolinoG, SecciaTM, IacoboneM, RossiGP. Data from: PTH modulation by aldosterone and angiotensin II is blunted in hyperaldosteronism and rescued by adrenalectomy. Research Data Unipd 2019. Deposited 16 January 2019. http:\/\/researchdata.cab.unipd.it\/61\/.","DOI":"10.1210\/jc.2019-00143"},{"issue":"5","key":"2019072014595019800_bib22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/cen.13734","article-title":"Effects of treatment with an angiotensin 2 receptor blocker and\/or vitamin D3 on parathyroid hormone and aldosterone: A randomized, placebo-controlled trial","volume":"103","author":"Bislev","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2019072014595019800_bib23","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/cen.13798","article-title":"Does angiotensin II regulate parathyroid hormone secretion or not","volume":"89","author":"Rossi","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2019072014595019800_bib24","doi-asserted-by":"crossref","first-page":"H286","DOI":"10.1152\/ajpheart.00535.2005","article-title":"Calcium paradox of aldosteronism and the role of the parathyroid glands","volume":"290","author":"Vidal","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"2019072014595019800_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000441-200507000-00001","article-title":"Bone loss in rats with aldosteronism","volume":"330","author":"Runyan","year":"2005","journal-title":"Am J Med Sci"},{"issue":"4","key":"2019072014595019800_bib26","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.HYP.33.4.981","article-title":"Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis","volume":"33","author":"Robert","year":"1999","journal-title":"Hypertension"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/9\/3726\/28969514\/jc.2019-00143.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T09:36:35Z","timestamp":1569058595000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/9\/3726\/5374694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,13]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2019-00143","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,9]]},"published":{"date-parts":[[2019,3,13]]}}}